Pricing Log in Create free account

Ascentage Pharma Group International - Unsponsored ADR (AAPG) vs ADARx Pharmaceuticals, Inc. (ADRX)

Ascentage Pharma Group International - Unsponsored ADR and ADARx Pharmaceuticals, Inc. are both Biotechnology companies. Ascentage Pharma Group International - Unsponsored ADR and ADARx Pharmaceuticals, Inc. are of similar size ($1.5B and $1.4B).

Valuation

Metric AAPG ADRX Biotechnology median
P/E — — 10.60
P/S — — 9.40
P/B n/m — 2.13
Price to free cash flow n/m — 25.18
EV/EBITDA n/m — 0.66
EV/Sales n/m — 9.02
Earnings yield — — (32.88%)
Free cash flow yield 0.00% — (23.13%)

Profitability

Metric AAPG ADRX Biotechnology median
Gross margin — — 68.51%
Operating margin — — 0.00%
Net margin — — 0.00%
Free cash flow margin 0.00% — 0.00%
Return on equity 0.00% — (51.96%)
Return on assets 0.00% — (46.06%)
Return on invested capital 0.00% — 0.00%

Growth

Metric AAPG ADRX Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) (177.78%) — 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric AAPG ADRX Biotechnology median
Debt to equity 3.70 — 0.00
Current ratio 1.22 — 4.97
Net debt to EBITDA 0.44 — 1.01

Dividend

Metric AAPG ADRX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric AAPG ADRX Biotechnology median
Market cap 1.41b 1.47b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack